ArticleDigestive diseases and sciences2003

Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.

Peter C Konturek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.